EUVIMEDEUVIMED entdecken
Open Access

High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021

Kavya Pathak, Claire Narang, Thomas J Hwang, Juan C Espinoza, Florence T Bourgeois

JAMA Pediatrics · 2023

DOI: 10.1001/jamapediatrics.2022.4131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Pediatrics, 2023. Verfasst von Kavya Pathak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Device Approval, Product Surveillance, Postmarketing. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This cohort study examines the characteristics of high-risk therapeutic devices approved by the US Food and Drug Administration for use in children and adolescents between 2016 and 2021.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Device ApprovalProduct Surveillance, PostmarketingUnited StatesHumansChildAdolescentUnited States Food and Drug AdministrationDrug Approval

Autor:innen und Institutionen

  • Harvard Medical School, Boston, Massachusetts.
  • Computational Health Informatics Program, Boston Children's Hospital, Boston, Massachusetts.
  • Division of Urological Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California.
  • Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.

Zitieren

APA

Pathak, K., Narang, C., Hwang, T. J., Espinoza, J. C., & Bourgeois, F. T. (2023). High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2022.4131

Vancouver

Pathak K, Narang C, Hwang TJ, Espinoza JC, Bourgeois FT. High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021. JAMA Pediatrics. 2023. doi:10.1001/jamapediatrics.2022.4131

BibTeX
@article{Pathak2023,
  author = {Pathak, Kavya and Narang, Claire and Hwang, Thomas J and Espinoza, Juan C and Bourgeois, Florence T},
  title = {High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021},
  journal = {JAMA Pediatrics},
  year = {2023},
  doi = {10.1001/jamapediatrics.2022.4131}
}
Kostenlos starten →